Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

In January 2022, Eckert & Ziegler Radiopharma GmbH (EZR), the radiopharmaceutical production arm of Eckert & Ziegler, signed a joint venture and exclusive long-term supply agreements for Ytterbium-176 with Atom Mines LLC, an innovative producer of enriched Ytterbium isotopes and a subsidiary of the non-profit Pointsman Foundation, both based in Austin, Texas.

Cancer therapies based on Lutetium-177 are proving highly effective, yet the world supply of Ytterbium-176, the indispensable precursor for production of no carrier added (nca) grade Lutetium-177,  has been previously reported to be only in grams per year. A new technology partially financed by EZR and developed by Atom Mines now promises to overcome this bottleneck: first samples delivered met the relevant quality criteria, in particular isotope purity. This opens the way for EZR to make  nca grade Lutetium-177 available in large quantities to pharmaceutical companies worldwide to treat hundreds of thousands of patients per year.

To read more please visit:

Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

Source: MarketScreener